Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Opioid Receptors
78%
Opioids
45%
δ Opioid Receptor
41%
G Protein-coupled Receptor
34%
Migraine
33%
Morphine
31%
Analgesic
26%
μ-opioid Receptor
26%
Nitroglycerin
25%
Synthetic Opioids
21%
Prodrug
21%
Kappa Opioid Receptor
19%
Arrestin
18%
Chronic Migraine
17%
Mouse Model
17%
G Protein
17%
Respiratory Depression
16%
Opioid Analgesics
15%
Hyperalgesia
15%
Opioid Antagonist
15%
Wireless
15%
Opioid-induced Hyperalgesia
15%
Analgesia
14%
Optogenetics
13%
Alkyl
13%
Antinociception
13%
SNC80
12%
δ-opioid Receptor Agonist
12%
Adverse Effects
12%
Headache
12%
Ventral Tegmental Area
11%
Mitragynine
11%
Antinociceptive
10%
Nucleus Accumbens
10%
Molecular Mechanism
10%
Receptor Agonist
10%
Knock-in Mouse Model
10%
Liver X Receptor
9%
REV-ERB
9%
Estrogen-related Receptor
9%
Inverse Agonist
9%
Splice Variants
9%
Receptor Activation
9%
Trigeminal Ganglion
9%
Allodynia
9%
Receptor Function
9%
Nuclear Receptor
9%
Neuroscience
8%
Transmembrane Domain
8%
Receptor Agonism
8%
Motivation
8%
Water Solubility
8%
Topical Delivery
8%
Exon 11
8%
Methyl
8%
Chronic Pain
8%
Selective Agonist
8%
Biased Agonism
8%
Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)
7%
Neuropathic Pain
7%
Locus Coeruleus
7%
Pharmacology
7%
Pharmacological Evaluation
7%
Synthetic Evaluation
7%
Structure-based Design
7%
Theophylline
7%
Transmembrane
7%
Kratom
7%
Cortical Spreading Depression
7%
Alkaloids
6%
β-lactamase
6%
Ex Vivo Human Skin
6%
Antitumor Activity
6%
Receptor Signaling
6%
Recent Advances
6%
Migraine Treatment
6%
Pain Treatment
6%
Medication Overuse Headache
6%
Endogenous Opioids
6%
Receptor-mediated
6%
Synthesized Compounds
6%
Microfluidics
6%
Multicomponent Reaction
6%
MOR-1
6%
Amino
6%
Alternative Splicing
6%
Inflammatory Pain
6%
Therapeutic Target
6%
5-HT2A Receptor
6%
Nucleus Accumbens Shell
6%
Agonism
6%
In Vivo Optogenetics
6%
Active State
6%
Fentanyl
6%
Rodents
6%
Physical Dependence
6%
Receptor Subtypes
6%
Behavioral Effects
6%
Opiates
5%
Neurovascular Coupling
5%
Pharmacology, Toxicology and Pharmaceutical Science
Opiate Receptor
100%
Receptor
64%
Analgesic Agent
50%
Migraine
35%
G Protein Coupled Receptor
33%
Delta Opiate Receptor
28%
Morphine
28%
Side Effect
26%
Opiate Agonist
26%
μ-Opioid Receptor
25%
Guanine Nucleotide Binding Protein
25%
Retina S Antigen
21%
Alkaloid
19%
Delta Opiate Receptor Agonist
19%
Mitragynine
19%
Respiration Depression
17%
Kappa Opiate Receptor
16%
Glyceryl Trinitrate
16%
Diseases
15%
Adverse Event
15%
Prodrug
15%
Antinociception
14%
Mouse Model
13%
Rat
11%
Narcotic Analgesic Agent
11%
Drug Dependence
10%
Hyperalgesia
10%
Inverse Agonist
9%
Headache
9%
Transformed Migraine
9%
Opiate
9%
Allodynia
9%
Neuropathic Pain
8%
Kappa Opiate Receptor Agonist
8%
Duragesic
8%
Peptide
8%
Carboxamide
7%
Structure Activity Relationship
7%
Radioligand
7%
Enzymes
6%
Receptor Agonist
6%
Knockout Mouse
6%
Cell Nucleus Receptor
6%
Anti-Inflammatory Drug
6%
Mu Opiate Receptor Agonist
6%
Chronic Pain
6%
Allosteric Modulator
6%
Inflammatory Pain
6%
Natural Product
6%
Drug Development
6%
Liver X Receptor
5%
Escherichia coli
5%
Carbonate Dehydratase
5%
Lead Compound
5%
Sulfur 35
5%
Lipid
5%
Benzenesulfonamide
5%
Inflammation
5%
Pharmacokinetics
5%
Functional Selectivity
5%
Indole
5%
Iodine-125
5%
Carfentanil
5%
Neoplasm
5%
Neuroscience
Receptor
70%
Migraine
46%
Agonist
41%
Behavior (Neuroscience)
37%
Delta Opiate Receptor
32%
In Vivo
31%
μ-Opioid Receptor
28%
Optogenetics
23%
Morphine
23%
Receptor Agonists
22%
Hyperalgesia
20%
Headache
20%
G Protein Coupled Receptor
19%
Nitroglycerin
17%
Locus Coeruleus
16%
Nucleus Accumbens
15%
Trigeminal Ganglion
13%
Ventral Tegmental Area
11%
Exon
11%
Analgesic
10%
Kappa Opiate Receptor
9%
Retina S Antigen
9%
Neuroscience
9%
G Protein
9%
Allodynia
8%
Alternative Splicing
8%
Trigeminal Nucleus
8%
Conditioned Place Preference
8%
Side Effect
7%
Basolateral Amygdala
7%
Hypophysis Adenylate Cyclase Activating Polypeptide
7%
Nicotine
7%
Aversion
7%
Internalization
7%
Iodine-125
7%
Nucleus Accumbens Shell
7%
Receptor Gene
6%
Circadian Rhythm
6%
Neural Circuit
6%
Brain Region
6%
5-HT2A Receptor
5%
Neurovascular Coupling
5%
Adenosine
5%
Interneuron
5%
Cholinergic
5%
Duragesic
5%
Fentanyl
5%
In Vitro
5%
Neuropeptide
5%
Dynorphin
5%
Genetics
5%
Nucleus
5%
Opiate
5%
Medication Overuse
5%
Radioligand
5%